Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nader Najafian, M.D.

Co-Author

This page shows the publications co-authored by Nader Najafian and Samia Khoury.
Connection Strength

0.789
  1. Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. J Clin Invest. 2003 Oct; 112(7):1037-48.
    View in: PubMed
    Score: 0.276
  2. T cell costimulatory pathways: blockade for autoimmunity. Expert Opin Biol Ther. 2003 Apr; 3(2):227-36.
    View in: PubMed
    Score: 0.267
  3. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest. 2001 Sep; 108(5):739-47.
    View in: PubMed
    Score: 0.060
  4. T cell costimulatory blockade as a novel immune intervention in autoimmune diseases. Clin Dermatol. 2001 Sep-Oct; 19(5):586-91.
    View in: PubMed
    Score: 0.060
  5. CD28-independent induction of experimental autoimmune encephalomyelitis. J Clin Invest. 2001 Mar; 107(5):575-83.
    View in: PubMed
    Score: 0.058
  6. In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity. J Clin Immunol. 2013 Jan; 33 Suppl 1:S43-9.
    View in: PubMed
    Score: 0.032
  7. Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med. 2007 Jul 09; 204(7):1691-702.
    View in: PubMed
    Score: 0.022
  8. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest. 2001 Apr; 107(7):909-16.
    View in: PubMed
    Score: 0.015
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.